# China NMPA Drug Inspection - Jilin Yimintang Pharmaceutical Co., Ltd. - Migraine Relief Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jilin-yimintang-pharmaceutical-co-ltd/978e19d3-f8c7-4a20-8efd-20bfa8ee96a4/
Source feed: China

> China NMPA drug inspection for Jilin Yimintang Pharmaceutical Co., Ltd. published July 16, 2021. Drug: Migraine Relief Capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Yunnan Provincial Drug Administration issued the second issue of the 2021 Drug Quality Bulletin.
- Company Name: Jilin Yimintang Pharmaceutical Co., Ltd.
- Publication Date: 2021-07-16
- Drug Name: Migraine Relief Capsules
- Inspection Finding: Compliant
- Action Taken: Supervision and spot checks

Company: https://www.globalkeysolutions.net/companies/jilin-yimintang-pharmaceutical-co-ltd/7eb64daa-fefa-45e6-8a15-d5a6c9b9c492/